Characterization of protein release from hydrolytically degradable poly(ethylene glycol) hydrogels.
We present a novel fully hydrophilic, hydrolytically degradable poly(ethylene glycol) (PEG) hydrogel suitable for soft tissue engineering and delivery of protein drugs. The gels were designed to overcome drawbacks associated with current PEG hydrogels (i.e., reaction mechanisms or degradation products that compromise protein stability): the highly selective and mild cross-linking reaction allowed for encapsulating proteins prior to gelation without altering their secondary structure as shown by circular dichroism experiments. Further, hydrogel degradation and structure, represented by mesh size, were correlated to protein release. It was determined that polymer density had the most profound effect on protein diffusivity, followed by the polymer molecular weight, and finally by the specific chemical structure of the cross-linker. By examining the diffusion of several model proteins, we confirmed that the protein diffusivity was dependent on protein size as smaller proteins (e.g., lysozyme) diffused faster than larger proteins (e.g., Ig). Furthermore, we demonstrated that the protein physical state was preserved upon encapsulation and subsequent release from the PEG hydrogels and contained negligible aggregation or protein-polymer adducts. These initial studies indicate that the developed PEG hydrogels are suitable for release of stable proteins in drug delivery and tissue engineering applications.
Zustiak
Silviya P
SP
Department of Chemical and Biochemical Engineering, University of Maryland, Baltimore, County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA.
Leach
Jennie B
JB
D002942:Circular Dichroism; D004058:Diffusion; D004337:Drug Carriers / Q000737:chemistry / Q000378:metabolism*; D020100:Hydrogels / Q000737:chemistry / Q000378:metabolism*; D008970:Molecular Weight; D011092:Polyethylene Glycols / Q000737:chemistry / Q000378:metabolism*; D017433:Protein Structure, Secondary; D011506:Proteins / Q000737:chemistry / Q000493:pharmacokinetics*
D004337:Drug Carriers; D020100:Hydrogels; D011506:Proteins; D011092:Polyethylene Glycols
Soft Matter. 2010 Aug 7;6(15):
24282439
J Control Release. 2000 Jan 3;63(1-2):155-63
10640589
J Pharm Sci. 1994 Apr;83(4):601-6
8046623
Protein Sci. 2001 Feb;10(2):250-61
11266611
Biomacromolecules. 2003 May-Jun;4(3):713-22
12741789
J Control Release. 2001 Sep 11;76(1-2):11-25
11532309
J Control Release. 1999 Nov 1;62(1-2):81-7
10518639
Biomaterials. 1998 Jul;19(14):1287-94
9720892
J Biomed Mater Res. 1989 Oct;23(10):1183-93
2808463
Retrovirology. 2008 Sep 22;5:83
18808674
Biomaterials. 2001 May;22(9):929-41
11311012
Soft Matter. 2006 Mar 16;2(4):343-349
32646132
J Control Release. 2004 Jan 8;94(1):195-205
14684283
J Pharm Sci. 1998 Nov;87(11):1450-8
9811505
Biotechnol Bioeng. 2004 Jun 30;86(7):747-55
15162450
J Control Release. 2014 Sep 28;190:31-2
25356469
Biomacromolecules. 2006 Apr;7(4):1335-43
16602758
Biotechnol Bioeng. 2003 Jun 5;82(5):578-89
12652481
Biomaterials. 2005 Jan;26(2):125-35
15207459
Biomaterials. 1996 Jun;17(12):1203-18
8799505
J Control Release. 2004 Mar 5;95(2):291-300
14980777
Biotechnol Bioeng. 2001 Oct 20;75(2):233-8
11536147
Pharm Res. 2000 Mar;17(3):351-7
10801225
J Biomed Mater Res. 2002 Jan;59(1):63-72
11745538
Biomacromolecules. 2005 Jan-Feb;6(1):290-301
15638532
J Control Release. 2007 Oct 8;122(3):287-96
17582636
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4623-8
19273853
Biomacromolecules. 2010 May 10;11(5):1348-57
20355705
J Control Release. 2002 Feb 19;79(1-3):137-45
11853925
Acta Biomater. 2007 Jul;3(4):449-55
17276150
Biomaterials. 1993 Dec;14(15):1117-26
8130315
Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14610-5
17804788
Chem Rev. 2001 Jul;101(7):1869-79
11710233
Biomaterials. 2001 Feb;22(4):363-9
11205440
Adv Drug Deliv Rev. 1997 Oct 13;28(1):5-24
10837562
J Control Release. 2005 Feb 16;102(3):619-27
15681084